Thurston Springer Miller Herd & Titak’s abrdn Healthcare Investors HQH Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio HQH Stock Details HQH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.38K	Hold	245	–	–	﹤0.01%	975
2026 Q1	$4.36K	Hold	245	–	–	﹤0.01%	1071
2025 Q4	$4.64K	Hold	245	–	–	﹤0.01%	1112
2025 Q3	$4.52K	Sell	245 -528	-68%	-$8.62K	0.01%	421
2025 Q2	$12K	Buy	773 +520	+206%	+$8.05K	﹤0.01%	1102
2025 Q1	$4.11K	Hold	253	–	–	﹤0.01%	1319
2024 Q4	$4.06K	Buy	253 +8	+3%	+$142	﹤0.01%	1053
2024 Q3	$4.56K	Buy	+245	New	+$4.57K	﹤0.01%	1217

Other funds holding HQH

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

SIC

Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

SAM

Smith Asset Management Chiefland, Florida $127M AUM 5.85% 1-Year Est. Return

NAS

NWF Advisory Services Los Angeles, California $1.06B AUM 48.27% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's HQH Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its abrdn Healthcare Investors (HQH) position steady in Q2 2026 at 245 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Thurston Springer Miller Herd & Titak first reported a position in HQH in Q3 2024 and has held it in 8 quarters since. The position peaked at $12K in Q2 2025. 45 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

Thurston Springer Miller Herd & Titak held 245 shares of abrdn Healthcare Investors worth $5.38K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its abrdn Healthcare Investors share count unchanged in Q2 2026.
abrdn Healthcare Investors made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #975 holding.
Thurston Springer Miller Herd & Titak first reported a position in abrdn Healthcare Investors in Q3 2024 and has held it in 8 quarters since.
Thurston Springer Miller Herd & Titak's abrdn Healthcare Investors position peaked at $12K in Q2 2025.
45 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.